Brought to you by 
Molecular Devices buys Axon Instruments for $134.4mm
25 Aug 2004
Executive Summary
Molecular Devices (bioanalytical measurement systems used in drug discovery) has acquired privately held Axon Instruments (microarray scanners) for about $134.4mm. It paid $0.1359 in cash and 0.00734 of an MD share for each outstanding Axon share, for a total of $68.7mm in cash, and 3.6mm common shares valued at $65.7mm.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Molecular Devices buys Axon Instruments for $134.4mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice